Table 3.
Effect of C-dECMs on chondrocyte/stem cell proliferation.
dECM origin | Seeded cell type | Treatment | Analysis | Results | Reference |
---|---|---|---|---|---|
human BMSC | human BMSC | seeded onto dECMs in the expansion medium for 14 days | cell number | strongly promoted proliferation with a low level of ROS | 96 |
human BMSC | human BMSC | seeded on dECMs | cell number | promoted cell proliferation | 95 |
human BMSC | human BMSC | cultured on TCPS coated with dECMs | DNA content | dECMs extracted in urea dramatically enhanced cell proliferation compared to collagen and HPMECM coating | 97 |
human BMSC (fetal and adult) | human adult BMSC | cultured on dECMs from fetal and adult BMSCs | cell number | superior proliferation on fetal dECMs compared to other conditions including TCPS and adult dECMs | 101 |
human BMSC | human BMSC | cultured on dECMs supplemented with melatonin | DNA content | promoted cell proliferation and improved melatonin-mediated cell proliferation | 100 |
human IFPSC | human IFPSC | expanded on dECMs | proliferation index | promoted stem cell proliferation | 65 |
human SDSC | human SDSC | expanded on dECMs by exposing to varied concentrations of H2O2 | proliferation index and cell number | promoted proliferation and alleviated oxidative stress-mediated proliferation reduction by lowering apoptosis rate and elevating G1 transition | 237 |
human SDSC (fetal and adult) | human adult SDSC | expanded on dECMs from fetal and adult SDSCs | cell number/ apoptotic percentage | promoted proliferation and decreased apoptosis; fetal dECM was higher proliferation than adult dECM | 69 |
human SDSC | human SDSC | expanded on dECMs | cell number | promoted cell proliferation | 140 |
human SDSC | human SDSC | expanded on dECMs and treated with sb203580 | cell number | enhanced proliferation and further enhanced by sb203580 preconditioning | 238 |
human UC-MSC | human UC-MSC | cultured on dECMs | DNA content | promoted UC-MSC proliferation compared to TCPS | 239 |
porcine chondrocyte | human BMSC | cultured on dECM–collagen microspheres | live/dead viability | supported cell survival after 7-day culture | 102 |
porcine chondrocyte | rabbit chondrocyte | seeded on physically prepared dECM in a culture medium | DNA content | supported chondrocyte proliferation | 240 |
porcine chondrocyte | rabbit chondrocyte | seeded on physically prepared dECM in a culture medium for 2 days, 2 weeks and 4 weeks | DNA content | supported chondrocyte proliferation | 241 |
porcine SDSC | porcine chondrocyte | cultured on dECMs | cell number | enhanced chondrocyte expansion | 99 |
porcine SDSC | porcine NPC | cultured on dECMs | cell number | enhanced NPC proliferation | 98 |
porcine SDSC | porcine SDSC | cultured on dECM | cell number | promoted proliferation compared to TCPS | 31 |
porcine SDSC | porcine SDSC | seeded on dECMs | cell number | greatly enhanced cell proliferation | 242 |
porcine SDSC | porcine SDSC | expanded on dECMs | p-cyclin D1 expression | enhanced SDSC proliferation | 217 |
porcine SDSC and chondrocyte | porcine SDSC and chondrocyte | expanded on dECMs from both SDSCs and chondrocytes | cell number | promoted cell proliferation during expansion on both dECMs, especially on SDSC-derived dECMs | 92 |
porcine SDSC and IFPSC | porcine IFPSC | expanded on dECMs from SDSCs/IPFSCs | cell number | enhanced cell proliferation | 91 |
porcine SDSC and NPC | porcine SDSC | cultured on dECMs from SDSCs, NPCs and SDSCs/NPCs that were fabricated under normoxia or hypoxia | cell number | enhanced in vitro proliferation, similar in normoxia- and hypoxia-made dECMs | 94 |
rat chondrocyte | rat chondrocyte | seeded on dECMs | cell number | promoted chondrocyte proliferation | 93 |
Abbreviations:BMSC: bone marrow stromal cell; dECM: decellularized extracellular matrix; HPMECM: pepsin digested mesenchymal stem cell-derived dECM; IPFSC: infrapatellar fat pad derived stem cell; NPC: nucleus pulposus cell; ROS: reactive oxygen species; SDSC: synovium derived stem cell; TCPS: tissue culture polystyrene; UC-MSC: umbilical cord derived mesenchymal stem cell.